Duality Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,493
Closed -$212K 783
2021
Q4
$212K Buy
+3,493
New +$207K 0.02% 463
2021
Q2
Sell
-35,246
Closed -$1.55M 689
2021
Q1
$1.55M Buy
35,246
+698
+2% +$29.3K 0.13% 270
2020
Q4
$1.21M Buy
34,548
+1,748
+5% +$62.1K 0.09% 309
2020
Q3
$1.2M Sell
32,800
-14,201
-30% -$528K 0.08% 332
2020
Q2
$1.76M Buy
+47,001
New +$1.88M 0.16% 178
2020
Q1
Sell
-28,489
Closed -$1.15M 241
2019
Q4
$1.15M Sell
28,489
-11,621
-29% -$433K 0.07% 259
2019
Q3
$1.39M Buy
+40,110
New +$1.32M 0.08% 227

Other funds holding PBH

Duality Advisers's PBH Position: Q1 2022 in Review

Duality Advisers sold out of Prestige Consumer Healthcare (PBH) in Q1 2022, closing a stake of 3,493 shares — an estimated $212K sold.

Duality Advisers first reported a position in PBH in Q3 2019 and held it in 7 quarters. The position peaked at $1.76M in Q2 2020. 287 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • Duality Advisers reported no remaining Prestige Consumer Healthcare position as of Q1 2022 after selling out during the quarter.
  • Duality Advisers sold 3,493 Prestige Consumer Healthcare shares in Q1 2022, an estimated $212K.
  • Duality Advisers first reported a position in Prestige Consumer Healthcare in Q3 2019 and held it in 7 quarters.
  • Duality Advisers's Prestige Consumer Healthcare position peaked at $1.76M in Q2 2020.
  • 287 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on Duality Advisers's 13F filing for Q1 2022, filed 9 May 2022.